Tuesday, September 26, 2017 12:04:46 PM
I also hope to start seeing Matt Benardis,new CEO of Cyrcadia Inc (CI) in public events trying to attract new investors. The main payments being received from Cyrcadia Asia (CA) are only $21,000 per month over the next 4 years. This money only serves to pay wages and little more. CI will need more cash to properly launch and scale the product in the US.
October will be the catalyst for what awaits us in the coming months. If we have positive news we can see the near future with optimism.
Nobody moves from here! Those who try to lower the price are getting it but will not get a relevant number of shares. As soon as we have any positive data the price will return to $0.004-$0.005.
IMPORTANT: The price is being manipulated downward, and should be at $0.0047 according to the 47% that LLBO owns from CI (currently raising money at $1/share). Any price below $0.0047 is not realistic as per the latest LLBO Q2 filling. As soon as we get FDA Class I approval, CI will start raising money at $2 or over, which will automatically raise LLBO price over $0.01. And as soon as CA starts selling in Asia we could easily see the price over $0.05 on future sales expectations.
TO SEE MY DUE DILIGENCE COMPILATION CLICK HERE
Disclaimer: This information is only my opinion and should not be considered as an advice or a recommendation to investors or potential investors in relation to holding, purchasing or selling securities or other financial products or instruments.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM